Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multigene Panel Testing Reveals Novel Variants in Hereditary Spherocytosis Patients in Türkiye | Turk J Haematol | 2025 | 39760301 | PubTator, text mining | PubMed |
| Identification of novel variants in hereditary spherocytosis patients by whole-exome sequencing. | Clin Chim Acta | 2025 | 39378964 | PubTator, text mining | PubMed |
| Identification of a novel SPTB gene splicing mutation in hereditary spherocytosis: a case report and diagnostic insights. | Front Genet | 2024 | 39959857 | PubTator, text mining | PubMed |
| "Do I need to reinvent myself?" Stigmatization of sport-related identities of Chinese students. | Front Psychol | 2024 | 39717467 | PubTator, text mining | PubMed |
| DNA regulatory element cooperation and competition in transcription. | BMB Rep | 2024 | 39523506 | PubTator, text mining | PubMed |
| Erythroblast enucleation at a glance. | J Cell Sci | 2024 | 39397781 | PubTator, text mining | PubMed |
| A Case of Adult Hereditary Spherocytosis Concomitant with Gilbert Syndrome Caused by Mutations in SPTB and UGT1A1. | J Inflamm Res | 2024 | 39247838 | PubTator, text mining | PubMed |
| Epigenetic Targeting of Heparan Sulfate 3-O- and 6-O-Sulfation in Breast Cancer Cells: Prospects for Attenuating Prothrombotic Tumor Cell Activities. | ACS Pharmacol Transl Sci | 2024 | 39144559 | PubTator, text mining | PubMed |
| Structure of the human dopamine transporter and mechanisms of inhibition. | Nature | 2024 | 39112705 | PubTator, text mining | PubMed |
| Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma. | Int Immunopharmacol | 2024 | 39067405 | PubTator, text mining | PubMed |
| Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease. | Oncol Ther | 2024 | 39012413 | PubTator, text mining | PubMed |
| Complex heterozygous mutations in hereditary spherocytosis: A case report. | World J Clin Cases | 2024 | 38983418 | PubTator, text mining | PubMed |
| Impact of imidacloprid exposure on gestational hyperglycemia: A multi-omics analysis. | Ecotoxicol Environ Saf | 2024 | 38850706 | PubTator, text mining | PubMed |
| Clinical Exome Sequencing Reveals Novel Mutations in SPTB Gene Associated with Hereditary Spherocytosis in Patients with Suspected Congenital Hemolytic Anemia. | Hemoglobin | 2024 | 38831725 | PubTator, text mining | PubMed |
| Secretory Phenotype in Peripheral Blood Mononuclear Cells of Elderly Patients with Rheumatoid Arthritis. | Rejuvenation Res | 2024 | 38814828 | PubTator, text mining | PubMed |
| Evaluation of a proteomic signature coupled with the kidney failure risk equation in predicting end stage kidney disease in a chronic kidney disease cohort. | Clin Proteomics | 2024 | 38762513 | PubTator, text mining | PubMed |
| Transcript-specific induction of stop codon readthrough using a CRISPR-dCas13 system. | EMBO Rep | 2024 | 38499809 | PubTator, text mining | PubMed |
| Novel mutation in alpha-spectrin gene in Saudi patients with hereditary spherocytosis. | Nucleosides Nucleotides Nucleic Acids | 2024 | 38319988 | PubTator, text mining | PubMed |
| Identification and validation of a 4-extracellular matrix gene signature associated with prognosis and immune infiltration in lung adenocarcinoma. | Heliyon | 2024 | 38293522 | PubTator, text mining | PubMed |
| Aseptic loosening around total joint replacement in humans is regulated by miR-1246 and miR-6089 via the Wnt signalling pathway. | J Orthop Surg Res | 2024 | 38287447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=4